Clinical Trial Update: A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing a long-term safety and clinical activity study of mRNA-3927 in participants previously enrolled in the mRNA-3927-P101 study f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Propionic Acidemia

Drugs mentioned

• mRNA-3927

Snippet

Sponsor: ModernaTX, Inc. | Conditions: Propionic Acidemia | Phase 1, Phase 2 | Status: RECRUITING